| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/25/2009 | CA2710006A1 Octahydroquinoli zines for antidiabetic treatment |
| 06/25/2009 | CA2708866A1 Bicyclic heterocyclic derivative |
| 06/24/2009 | EP2072522A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 06/24/2009 | EP2072519A1 Diaryl ketimine derivative |
| 06/24/2009 | EP2072515A1 Substituted quinazolidines for antidiabetic treatment |
| 06/24/2009 | EP2072048A1 Use of pinolenic acid for the treatment of obesity |
| 06/24/2009 | EP1863812A4 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 06/24/2009 | EP1660131B1 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity |
| 06/24/2009 | EP1611109A4 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 06/24/2009 | EP1558567B1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 06/24/2009 | EP1483247B1 Aryl substituted pyrimidines and the use thereof |
| 06/24/2009 | EP1445258B1 Activator for peroxisome proliferator-activated receptor delta |
| 06/24/2009 | EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 06/24/2009 | EP1224861B1 Test method relating to adipose cells and to obesity by using a human h-pgds overexpressing non-human animal |
| 06/24/2009 | CN101461804A (+)-1-(3,4-dichlorrophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 06/24/2009 | CN100503637C Glucagon-like peptide analog, its composition and its using method |
| 06/24/2009 | CN100503608C Deazapurines and uses thereof |
| 06/24/2009 | CN100503605C Benzimidazole derivative and its use as AII receptor antagonist |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503574C Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 06/24/2009 | CN100503572C Caspase inhibitors and uses thereof |
| 06/24/2009 | CN100503560C Substituted cyclohexane derivatives |
| 06/24/2009 | CN100502893C Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 06/23/2009 | USRE40792 treating CANCER, PMS, MENOPAUSE AND HYPERCHOLESTEROLEMIA with plant extract of soya or clover and isoflavones from Genistein, Daidzein, Biochanin A, Formononetin or the natural glycosides; dosage forms |
| 06/23/2009 | US7550494 Small molecules useful in the treatment of inflammatory disease |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550473 Pyrimidine derivatives useful as inhibitors of PKC-theta |
| 06/23/2009 | US7550455 8-(piperazin-1yl)- and 8-([1,4]diazepan-1yl)-xanthines, the preparation thereof and their use as pharmaceutical composition |
| 06/23/2009 | US7550429 treating mammal to a weight reduction or reduction in obesity; biodrug as antilipolytic agents |
| 06/23/2009 | CA2504735C Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/23/2009 | CA2492804C Novel inhibitors of kinases |
| 06/23/2009 | CA2449874C New indole derivatives with 5-ht6 receptor affinity |
| 06/23/2009 | CA2433285C Blood lipid ameliorating composition |
| 06/23/2009 | CA2420694C Guanidinobenzamides as mc4-r agonists |
| 06/23/2009 | CA2389219C Dry powder compositions having improved dispersivity |
| 06/18/2009 | WO2009076631A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 06/18/2009 | WO2009076593A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 06/18/2009 | WO2009075835A1 CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1 |
| 06/18/2009 | WO2009075277A1 4-aminopyrimidine derivative and medicinal composition containing the compound |
| 06/18/2009 | WO2009075216A1 Therapeutic agent for ulcer |
| 06/18/2009 | WO2009074969A2 Spingosine-1-phosphate, analogues and antagonists for use as medicaments |
| 06/18/2009 | WO2009074835A1 Dose reduction of a cannabinoid cb1 receptor antagonist in the treatment of overweight or obesity |
| 06/18/2009 | WO2009074789A1 Amido-thiophene compounds and their use as 11-beta-hsd1 inhibitors |
| 06/18/2009 | WO2009074782A1 Cannabinoid receptor modulators |
| 06/18/2009 | WO2009074487A1 Inhibitors of stearoyl-coa desaturase |
| 06/18/2009 | WO2009074300A2 Hedgehog pathway antagonists and therapeutic applications thereof |
| 06/18/2009 | WO2009074157A1 Fully-modified phenyl pyrrole aminoguanidines |
| 06/18/2009 | WO2009073973A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/18/2009 | WO2009073947A1 ORGANIC SALTS OF β-ALANINE |
| 06/18/2009 | WO2009073944A1 USE OF PYRIDOXINE α-HYDROXYISOCAPROATE TO REDUCE METABOLIC ACIDOSIS AND AMMONIA ACCUMULATION |
| 06/18/2009 | WO2009073943A1 Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (hica) |
| 06/18/2009 | WO2009054693A3 Process for the preparation of atorvastatin |
| 06/18/2009 | WO2009046864A3 Use of the human pancreatic polypeptide as a therapeutic agent |
| 06/18/2009 | WO2009046847A3 Use of peptide ll-37 as a therapeutic agent |
| 06/18/2009 | WO2009046846A3 Use of il-1 receptor peptide, alone or in combination with peptide ll-37, as a therapeutic agent |
| 06/18/2009 | WO2009043476A3 Neuromedin s as a therapeutic agent |
| 06/18/2009 | WO2009043448A3 Neuromedin u-25 and neuromedin s as therapeutic agents |
| 06/18/2009 | WO2009043440A3 Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agent |
| 06/18/2009 | WO2009038385A3 Novel compounds having indazole frameworks, methods for preparing the same and pharmaceutical composition comprising the same |
| 06/18/2009 | WO2009015485A8 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 06/18/2009 | WO2008129426A3 Medicaments and methods to treat autoimmune disease and cancer |
| 06/18/2009 | WO2008099000A3 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions |
| 06/18/2009 | WO2008068174A9 4,5,6,7-tetrahydro-thieno [2,3-c] pyridines as h3 modulators |
| 06/18/2009 | WO2008065457A3 Herbal mixture with fraxinus, achillea and melissa to improve metabolism, boost immunity and help in therapy |
| 06/18/2009 | WO2008057855A9 Heterocyclic compounds as modulators of glucocorticoid receptor, ap-i, and/or np-kappa-b activity |
| 06/18/2009 | WO2007124337A8 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| 06/18/2009 | US20090156803 Condensed furan compounds |
| 06/18/2009 | US20090156681 Compounds for the treatment of metabolic disorders |
| 06/18/2009 | US20090156665 Compositions Comprising Flavonoids and Toctrienols and Methods Thereof |
| 06/18/2009 | US20090156663 Functional Foods Comprising Flavonoids and Tocotrienols and Methods Thereof |
| 06/18/2009 | US20090156662 Fat Absorption Inhibitor |
| 06/18/2009 | US20090156655 Used to treat diabetic and other glucagon related metabolic disorders such as obesity, hyperglycemia, atherosclerosis, ischemic heart disease, stroke, neuropathy, and wound healing; (4-[1-(2,6-Dimethyl-4'-trifluoromethyl-biphenyl-4-yloxy)-3,3-dimethyl-butyl]-N-(1H-tetrazol-5-ylmethyl)-benzamide |
| 06/18/2009 | US20090156647 Method for maintaining physiological pH levels during intensive physical exercise |
| 06/18/2009 | US20090156640 Nociceptin analogs |
| 06/18/2009 | US20090156635 Biaryloxymethylarenecarboxylic acids as glycogen synthase activators |
| 06/18/2009 | US20090156633 Heterocyclic quinolone derivatives that inhbit prolyl hydroxylase activity |
| 06/18/2009 | US20090156623 N-aryl piperidine substituted biphenylcarboxamides |
| 06/18/2009 | US20090156614 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 06/18/2009 | US20090156597 Novel Compounds |
| 06/18/2009 | US20090156579 Combination of a Dipeptidyl Peptidase-4 Inhibitor and an Anti-Hypertensive Agent for the Treatment of Diabetes and Hypertension |
| 06/18/2009 | US20090156574 N-(4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl)-4-((4-oxopiperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agents |
| 06/18/2009 | US20090156558 Phosphonate analogs of antimetabolites |
| 06/18/2009 | US20090156521 Gpr17 modulators,method of screening and uses thereof |
| 06/18/2009 | US20090156516 Benzylphenyl cyclohexane derivatives and methods of use |
| 06/18/2009 | US20090156507 Cell permeable conjugates of peptides for inhibition of protein kinases |
| 06/18/2009 | US20090156494 Compositions and methods comprising gastrin compounds |
| 06/18/2009 | US20090156493 Urocortin-iii and uses thereof |
| 06/18/2009 | US20090156487 Infant nutritional compositions for preventing obesity |
| 06/18/2009 | US20090156478 Acylated GLP-1 Compounds |
| 06/18/2009 | US20090156465 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
| 06/18/2009 | US20090156458 Assay for the detection of factors that modulate the expression of inagp |
| 06/18/2009 | US20090155906 Cell differentiation suppressing agent, method of culturing cells using the same, culture solution, and cultured cell line |
| 06/18/2009 | US20090155392 Methods and Systems for Sublingual Guarana Administration |
| 06/18/2009 | US20090155384 Methods and compositions for the sustained release of chromium |
| 06/18/2009 | US20090155380 Non-medicinal food additive for animals, supplemented foods containing same and method for improving animal growth |
| 06/18/2009 | US20090155376 Protein hydrolysate with antidiabetic effect |
| 06/18/2009 | US20090155292 Compositions and methods for the prevention and treatment of autoimmune conditions |
| 06/18/2009 | US20090155281 Methods of using antibodies that bind both bcma and taci |
| 06/18/2009 | US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa |
| 06/18/2009 | US20090155201 Alkylated poly(allylamine) polymers and methods of use |